Switzerland
As Global Head of Pharmaceutical Development, my current focus is combining AI and Human Excellence to accelerate patient impact. Integrating AI into CMC development is essential for scaling innovation and managing the growing complexity of an increasingly diverse portfolio. By smart technology integration in our day-to-day operating model, we are successfully accelerating development timelines while maintaining a lean, efficient organization.
Development of innovative drug formulations and delivery systems for biological and chemical entities. Analytical development and characterization of drug substances and drug products. Clinical manufacturing of drug products.
Responsible for the pharmaceutical and analytical development of Biotech products (New Biological Entities NBEs) at Merck Healthcare, the pharmaceutical division of Merck KGaA, Darmstadt, Germany
Responsible for the analytical development of Biotech products (New Biological Entities NBEs) at MerckSerono, the pharmaceutical division of Merck KGaA, Darmstadt, Germany
Development and execution of a Operational Excellence Strategy for the Pharma Production of Merck Darmstadt (3 Plants). Member of the Site Network Leadership Team reporting to the Head of Pharma Production, Darmstadt.
Head of Quality Assurance and Quality Control. Board member of the Merck Biosciences AG, Läufelfingen, Switzerland.